EMS Pharmaceutical Supplies

The City of Orlando is seeking a qualified pharmaceutical supplier for the Orlando Fire Department (OFD) through an Invitation for Bid (IFB25-0494) for EMS Pharmaceutical Supplies. The procurement aims to establish a three-year contract with potential renewal for two additional 12-month periods, totaling up to five years. The solicitation covers 48 different pharmaceutical items, including critical emergency medications such as Adenosine, Albuterol, Epinephrine, and Narcan, with quantities ranging from 1 to 1,400 units per item. The key objectives include ensuring a consistent, reliable, and high-quality range of pharmaceutical products to support emergency medical services and community health. The bid is scheduled for release on July 31, 2025, with a non-mandatory pre-bid conference on August 11, 2025, and proposals due on September 2, 2025, at 2:00 PM via a virtual electronic submission process. Bidders must submit complete electronic responses through the City's e-Procurement Portal, with paper responses being considered non-responsive. The city may award the contract on a lump sum, per group, or per item basis to the most responsive and responsible bidder.

Potential respondents must meet specific qualifications, including providing detailed information about years in business, local service facilities, and payment terms. The procurement includes several mandatory certifications, such as a Scrutinized Companies Certification and a Human Trafficking Affidavit. Vendors are required to provide documentation on recycled content, payment preferences, and willingness to serve as a secondary supplier if not selected as the primary contractor. While specific budget ranges are not explicitly stated, the comprehensive nature of the pharmaceutical supply contract suggests a significant procurement value. The solicitation does not mention specific set-aside designations or restrictions for disadvantaged enterprises. The contract will be awarded to the supplier that demonstrates the ability to consistently provide high-quality pharmaceutical supplies that comply with all relevant regulatory requirements and standards. The potential contract kick-off is scheduled for October 20 or 23, 2025, following potential council meetings and contract execution in October 2025.